Partial Splenic Embolization as Treatment of Idiopathic Thrombocytopenic Purpura: A Case Report

The use of splenic embolization in immune thrombocytopenia: A systematic review and meta‐analysis

“…After exclusion of review publications and duplicate reports, 24 reports were included in the final analysis. Nine studies included five or more patients and these were used in the analysis of effectiveness (228 patients), 7,13,34–40 and 15 studies were included in the safety analysis (151 patients) 13,16,22,31,33–35,37–44 …”

“…Most studies did not include the descriptions of pain intensity assessment or strategies for pain control following embolization. While two studies provided the detailed measures of pain management, using continuous opioid infusion for up to 72 h post‐embolization, 13,33 others mentioned that post‐procedural pain was controlled with opioids without specific details 35,43 . Additionally, to mitigate the risk of post‐embolization infection in splenic tissue, certain studies employed post‐procedural prophylactic antimicrobial therapy 13,33,35,40 …”

“…Nine studies included five or more patients and these were used in the analysis of effectiveness (228 patients), 7,13,[34][35][36][37][38][39][40] and 15 studies were included in the safety analysis (151 patients). 13,16,22,31,[33][34][35][37][38][39][40][41][42][43][44]…”

“…49,64 There are limited data on post-embolization pain assessment and management. Based on the authors' experience and findings from the few reports addressing post-SE pain management, 13,33,35,43 it is generally observed that post-embolization syndrome often involves treatment with either scheduled, continuous or patient-controlled analgesia using opioid pain-relieving medications such as morphine or fentanyl.…”